Varahram Shahryari

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.

Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.

Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.

MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

miRNA-708 control of CD44(+) prostate cancer-initiating cells.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.

MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.

Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.